call Toll Free (US/Canada) : +1 866 658 6826 | call +1 425 320 4776 | call (UK) : +44 1865 60 0662 | email info(@)blueweaveconsulting.com
Home | About Us | Career | Services | Blog | Contact Us
Blueweave
Asia Pacific Apheresis Market
Inquire Before Buying Request for Sample

Asia Pacific Apheresis Market

Home Healthcare And Pharmaceutical Asia Pacific Apheresis Market

SPECIAL OFFER : 25% Super Discount For All !

Asia Pacific Apheresis Market, By Product (Devices, Disposables); By Procedures (Leukapheresis, Plasmapheresis, Plateletpheresis, Erythrocytapheresis); By Technology (Centrifugation, Membrane Separation); By Application (Renal Disorders, Hematological Disorders, Neurological Disorders, Autoimmune Disorders); By Country (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Vietnam, Rest of Asia Pacific), Trend Analysis, Competitive Landscape & Forecast, 2019–2029

  • Published Date: November 2023
  • Report ID: BWC23891
  • Available Format: PDF
  • Page: 240

Report Overview

Increasing prevalence of chronic diseases, rising demand for blood components, advancements in healthcare infrastructure, growing awareness about apheresis therapies, growing elderly population, technological innovations, and government initiatives could boost the growth of Asia-Pacific Apheresis Market during the forecast period between 2023 and 2029.

Asia-Pacific Apheresis Market - Industry Trends & Forecast Report, 2029

The Asia-Pacific apheresis market size was estimated at USD 1.98 billion in 2022. During the forecast period between 2023 and 2029, the size of Asia-Pacific apheresis market is projected to grow at a CAGR of 10.32% reaching a value of USD 3.57 billion by 2029. Asia-Pacific apheresis market is driven by the rising prevalence of chronic diseases, such as cancer and autoimmune disorders, that drives the demand for therapeutic apheresis procedures. Also, advancements in healthcare infrastructure and technology in the region improved access to apheresis services. The growing aging population led to an increased need for apheresis in managing age-related conditions. Further, the expanding awareness about the benefits of apheresis in treating various medical conditions and the increasing availability of skilled healthcare professionals contribute to market growth. On top of that, supportive government initiatives and investments in healthcare also fuel the market's expansion.

Asia Pacific Apheresis Market

Apheresis - Overview

Apheresis is a medical procedure that involves removing blood from a patient, separating its components (such as red blood cells, plasma, platelets, or specific disease-causing substances), and returning the desired components to the patient's circulation. This therapeutic technique is used for various purposes, including treating conditions like autoimmune diseases, leukemia, and certain neurological disorders by removing harmful substances from the blood or collecting specific blood components for transfusion. Apheresis is essential in managing and mitigating specific medical conditions, helping to improve a patient's overall health and well-being through targeted blood component manipulation.

Asia-Pacific Apheresis Market

Growth Drivers

Advancements in Healthcare Infrastructure

Asia-Pacific apheresis market is experiencing robust growth due to significant advancements in the region's healthcare infrastructure. The increasing prevalence of chronic diseases, such as cancer, autoimmune disorders, and blood-related conditions, led to a rising demand for apheresis procedures. Also, growing awareness among healthcare professionals and patients about the benefits of apheresis in disease management is fueling market expansion. Further, technological innovations in apheresis devices and procedures are enhancing treatment efficacy and boosting adoption rates. With these factors combined, the Asia-Pacific apheresis market is on a trajectory of sustained growth, offering improved therapeutic options for patients across the region.

Restraints

Regulatory Hurdles

Asia-Pacific apheresis market faces a significant restraint in the form of stringent regulatory requirements. Government agencies across the region have implemented complex and time-consuming approval processes for apheresis devices and related therapies. These regulations not only delay product launches but also increase compliance costs for manufacturers. Also, varying regulatory standards among different countries within the region create a fragmented landscape that hampers market expansion and harmonization. Companies operating in the Asia-Pacific apheresis market must navigate these intricate regulatory pathways, leading to a challenging environment for innovation and market penetration.

Impact of COVID-19 on Asia-Pacific Apheresis Market

Asia-Pacific apheresis market experienced significant impacts due to COVID-19. The pandemic led to an increased demand for apheresis procedures to treat critically ill COVID-19 patients, particularly for plasma exchange to manage severe cases. However, disruptions in the healthcare system, lockdowns, and restrictions on non-essential medical procedures initially hindered market growth. Supply chain disruptions also affected the availability of apheresis equipment and consumables. Despite these challenges, the market eventually rebounded as healthcare systems adapted to the new normal, emphasizing the importance of apheresis in treating COVID-19 complications, thereby driving growth in the Asia-Pacific apheresis market.

Asia-Pacific Apheresis Market

Segmental Coverage

Asia-Pacific Apheresis Market - By Product

By product, Asia-Pacific apheresis market is divided into Devices and Disposables segments. The devices segment represents the larger portion of the market. This category encompasses various medical instruments and machines used for apheresis procedures, such as centrifugation devices and plasmapheresis machines. These essential devices are instrumental in the separation and collection of blood components for therapeutic purposes. The Devices segment's prominence underscores the critical role technology plays in advancing apheresis techniques and ensuring the efficient extraction of vital blood components, making it a significant driver of growth within the Asia-Pacific apheresis market.

Asia-Pacific Apheresis Market - By Procedure

By procedures, Asia-Pacific apheresis market is divided into Leukapheresis, Plasmapheresis, Plateletpheresis, and Erythrocytapheresis segments. Plasmapheresis stands out as one of the largest segments. This therapeutic procedure involves the separation and removal of plasma from the blood, which is crucial in treating various medical conditions, including autoimmune diseases, neurological disorders, and certain blood disorders. With an increasing prevalence of these health issues across the Asia-Pacific region, the plasmapheresis segment is witnessing significant growth, driven by the demand for effective therapeutic interventions, making it a prominent and sizable component of the regional apheresis market.

Asia Pacific Apheresis Market Size

Asia-Pacific Apheresis Market - By Technology

By technology Asia-Pacific apheresis market is splits into Centrifugation and Membrane Separation segments. The centrifugation segment holds the dominant position in the region, indicating a higher market share and revenue compared to the membrane separation segment. This could be attributed to the widespread use of centrifugation techniques in various medical and therapeutic applications, such as blood component separation and plasma exchange, which are vital in treating various medical conditions. The centrifugation segment's prominence underscores its significance in the apheresis market within the Asia-Pacific region.

Asia-Pacific Apheresis Market - By Application

By application, the Asia-Pacific apheresis market is divided into Renal Disorders, Hematological Disorders, Neurological Disorders, and Autoimmune Disorders segments. The hematological disorders segment is the largest in the Asia-Pacific apheresis market, which covers a wide range of conditions affecting the blood, such as anemia, leukemia, and hemophilia. This segment's prominence can be attributed to the prevalence of hematological disorders in the region, necessitating apheresis procedures for therapeutic interventions and the collection of blood components. Therefore, it plays a pivotal role in shaping the Asia-Pacific apheresis market's dynamics and growth trajectory.

Asia-Pacific Apheresis Market - By Country

By country, Asia-Pacific apheresis market is divided into China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Vietnam, and Rest of APAC. China is the largest segment in the Asia-Pacific apheresis market. This populous nation with a rapidly growing healthcare sector represents a substantial portion of the market due to its sheer population size and increasing demand for apheresis procedures. China's robust healthcare infrastructure and a rising number of patients requiring apheresis treatments make it a significant contributor to the overall market. While other countries in the region also play vital roles, such as India and Japan, China's dominance in terms of population and healthcare development gives it the largest share within the Asia-Pacific apheresis market.

Competitive Landscape

Asia-Pacific apheresis market is fiercely competitive, with major players including Asahi Kasei Corporation, B. Braun SE, Fresenius SE & Co. KGAA, Haemonetics Corporation, Terumo Corporation, Kaneka Corporation, Sumitomo Bakelite Company Limited, and Medica SPA. The key strategies used by these market leaders are new product launches, mergers and acquisitions, and alliances. To grow their market share, these companies are also focusing on investing in innovations, collaborations, and expansions.

Recent Developments

  • In August 2022 - Haemonetics Corporation signed an agreement with Epic, a leading Electronic Health Record (EHR) system, to offer Haemonetics' Safe Trace Tx blood bank information system to Epic's global network of hospitals.

Scope of the Report

Attributes

Details

Years Considered

Historical Data – 2019–2022

Base Year – 2022

Estimated Year – 2023

Forecast Period – 2023–2029

Facts Covered

Revenue in USD Million

Market Coverage

China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Vietnam, Rest of Asia Pacific

Product/ Service Segmentation

Product, Procedures, Technology, Application, Country

Key Players

Asahi Kasei Corporation, B. Braun SE, Fresenius SE & Co. KGAA, Haemonetics Corporation, Terumo Corporation, Kaneka Corporation, Sumitomo Bakelite Company Limited, Medica SPA

 

By Product

  • Devices

  • Disposables

By Procedures

  • Leukapheresis

  • Plasmapheresis

  • Plateletpheresis

  • Erythrocytapheresis

By Technology

  • Centrifugation

  • Membrane Separation

By Application

  • Renal Disorders

  • Hematological Disorders

  • Neurological Disorders

  • Autoimmune Disorders

By Country

  • China

  • India

  • Japan

  • South Korea

  • Australia & New Zealand

  • Indonesia

  • Malaysia

  • Singapore

  • Vietnam

  • Rest of APAC

  1. Research Framework
    1. Research Objective
    2. Product Overview
    3. Market Segmentation
  2. Executive Summary
  3. Asia-Pacific Apheresis Market Insights
    1. Industry Value Chain Analysis
    2. DROC Analysis
      1. Growth Drivers
        1. Increasing prevalence of chronic diseases
        2. Growing demand for blood components
      2. Restraints
        1. High cost of apheresis procedures
      3.  Opportunities
        1. Advancement in technology
      4. Challenges
        1. Lack of trained professionals
    3. Technological Advancements/Recent Developments
    4. Regulatory Framework
    5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
  4. Asia-Pacific Apheresis Market Overview
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Product
        1. Devices
        2. Disposables
      2. By Procedure
        1. Leukapheresis
        2. Plasmapheresis
        3. Plateletpheresis
        4. Erythrocytapheresis
        5. Others
      3. By Technology
        1. Centrifugation
        2. Membrane Separation
      4. By Application
        1. Renal Disorders
        2. Hematological Disorders
        3. Neurological Disorders
        4. Autoimmune Disorders
        5. Others
      5. By Country
        1. China
        2. India
        3. Japan
        4. South Korea
        5. Australia & New Zealand
        6. Indonesia
        7. Malaysia
        8. Singapore
        9. Vietnam
        10. Rest of Asia-Pacific
  5. China Apheresis Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Product
      2. By Procedure
      3. By Technology
      4. By Application
  6. India Apheresis Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Product
      2. By Procedure
      3. By Technology
      4. By Application
  7. Japan Apheresis Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Product
      2. By Procedure
      3. By Technology
      4. By Application
  8. South Korea Apheresis Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Product
      2. By Procedure
      3. By Technology
      4. By Application
  9. Australia & New Zealand Apheresis Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Product
      2. By Procedure
      3. By Technology
      4. By Application
  10. Indonesia Apheresis Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Product
      2. By Procedure
      3. By Technology
      4. By Application
  11. Malaysia Apheresis Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Product
      2. By Procedure
      3. By Technology
      4. By Application
  12. Singapore Apheresis Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Product
      2. By Procedure
      3. By Technology
      4. By Application
  13. Vietnam Apheresis Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Product
      2. By Procedure
      3. By Technology
      4. By Application
  14. Rest of Asia-Pacific Apheresis Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Product
      2. By Procedure
      3. By Technology
      4. By Application
  15. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Asia-Pacific Apheresis Company Market Share Analysis, 2022
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
  16. Impact of COVID-19 on Asia-Pacific Apheresis Market
  17. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
    1. Asahi Kasei Corporation
    2. B. Braun SE
    3. Fresenius SE & Co. KGAA
    4. Haemonetics Corporation
    5. Terumo Corporation
    6. Kaneka Corporation
    7. Sumitomo Bakelite Company Limited
    8. Medica SPA
    9. Other Prominent Players
  18. Key Strategic Recommendations
  19. Research Methodology
    1.   Qualitative Research
      1.  Primary & Secondary Research
    2.   Quantitative Research
    3.   Market Breakdown & Data Triangulation
      1.  Secondary Research
      2.  Primary Research
    4.   Breakdown of Primary Research Respondents, By Country
    5.   Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable

 

List of Figures

 

Figure 1       Asia-Pacific Apheresis Segmentation

Figure 2       Asia-Pacific Apheresis Market Value Chain Analysis

Figure 3       Company Market Share Analysis, 2022

Figure 4       Asia-Pacific Apheresis Market Size, By Value (USD Million), 2019–2029

Figure 5       Asia-Pacific Apheresis Market Share, By Product, By Value, 2019–2029

Figure 6       Asia-Pacific Apheresis Market Share, By Procedure, By Value, 2019–2029

Figure 7       Asia-Pacific Apheresis Market Share, By Technology, By Value, 2019–2029

Figure 8       Asia-Pacific Apheresis Market Share, By Application, By Value, 2019–2029

Figure 9       Asia-Pacific Apheresis Market Share, By Country, By Value, 2019–2029

Figure 10     China Apheresis Market Size, By Value (USD Million), 2019–2029

Figure 11     China Apheresis Market Share, By Product, By Value, 2019–2029

Figure 12     China Apheresis Market Share, By Procedure, By Value, 2019–2029

Figure 13     China Apheresis Market Share, By Technology, By Value, 2019–2029

Figure 14     China Apheresis Market Share, By Application, By Value, 2019–2029

Figure 15     India Apheresis Market Size, By Value (USD Million), 2019–2029

Figure 16     India Apheresis Market Share, By Product, By Value, 2019–2029

Figure 17     India Apheresis Market Share, By Procedure, By Value, 2019–2029

Figure 18     India Apheresis Market Share, By Technology, By Value, 2019–2029

Figure 19     India Apheresis Market Share, By Application, By Value, 2019–2029

Figure 20     Japan Apheresis Market Size, By Value (USD Million), 2019–2029

Figure 21     Japan Apheresis Market Share, By Product, By Value, 2019–2029

Figure 22     Japan Apheresis Market Share, By Procedure, By Value, 2019–2029

Figure 23     Japan Apheresis Market Share, By Technology, By Value, 2019–2029

Figure 24     Japan Apheresis Market Share, By Application, By Value, 2019–2029

Figure 25     South Korea Apheresis Market Size, By Value (USD Million), 2019–2029

Figure 26     South Korea Apheresis Market Share, By Product, By Value, 2019–2029

Figure 27     South Korea Apheresis Market Share, By Procedure, By Value, 2019–2029

Figure 28     South Korea Apheresis Market Share, By Technology, By Value, 2019–2029

Figure 29     South Korea Apheresis Market Share, By Application, By Value, 2019–2029

Figure 30     Australia & New Zealand Apheresis Market Size, By Value (USD Million), 2019–2029

Figure 31     Australia & New Zealand Apheresis Market Share, By Product, By Value, 2019–2029

Figure 32     Australia & New Zealand Apheresis Market Share, By Procedure, By Value, 2019–2029

Figure 33     Australia & New Zealand Apheresis Market Share, By Technology, By Value, 2019–2029

Figure 34     Australia & New Zealand Apheresis Market Share, By Application, By Value, 2019–2029

Figure 35     Indonesia Apheresis Market Size, By Value (USD Million), 2019–2029

Figure 36     Indonesia Apheresis Market Share, By Product, By Value, 2019–2029

Figure 37     Indonesia Apheresis Market Share, By Procedure, By Value, 2019–2029

Figure 38     Indonesia Apheresis Market Share, By Technology, By Value, 2019–2029

Figure 39     Indonesia Apheresis Market Share, By Application, By Value, 2019–2029

Figure 40     Malaysia Apheresis Market Size, By Value (USD Million), 2019–2029

Figure 41     Malaysia Apheresis Market Share, By Product, By Value, 2019–2029

Figure 42     Malaysia Apheresis Market Share, By Procedure, By Value, 2019–2029

Figure 43     Malaysia Apheresis Market Share, By Technology, By Value, 2019–2029

Figure 44     Malaysia Apheresis Market Share, By Application, By Value, 2019–2029

Figure 45     Singapore Apheresis Market Size, By Value (USD Million), 2019–2029

Figure 46     Singapore Apheresis Market Share, By Product, By Value, 2019–2029

Figure 47     Singapore Apheresis Market Share, By Procedure, By Value, 2019–2029

Figure 48     Singapore Apheresis Market Share, By Technology, By Value, 2019–2029

Figure 49     Singapore Apheresis Market Share, By Application, By Value, 2019–2029

Figure 50     Vietnam Apheresis Market Size, By Value (USD Million), 2019–2029

Figure 51     Vietnam Apheresis Market Share, By Product, By Value, 2019–2029

Figure 52     Vietnam Apheresis Market Share, By Procedure, By Value, 2019–2029

Figure 53     Vietnam Apheresis Market Share, By Technology, By Value, 2019–2029

Figure 54     Vietnam Apheresis Market Share, By Application, By Value, 2019–2029

Figure 55     Rest of Asia-Pacific Apheresis Market Size, By Value (USD Million), 2019–2029

Figure 56     Rest of Asia-Pacific Apheresis Market Share, By Product, By Value, 2019–2029

Figure 57     Rest of Asia-Pacific Apheresis Market Share, By Procedure, By Value, 2019–2029

Figure 58     Rest of Asia-Pacific Apheresis Market Share, By Technology, By Value, 2019–2029

Figure 59     Rest of Asia-Pacific Apheresis Market Share, By Application, By Value, 2019–2029                  

 

 

 

List of Tables

 

Table 1        Asia-Pacific Apheresis Market Size, By Value (USD Million), 2019–2029

Table 2        Asia-Pacific Apheresis Market Size, By Product, By Value, 2019–2029

Table 3        Asia-Pacific Apheresis Market Size, By Procedure, By Value, 2019–2029

Table 4        Asia-Pacific Apheresis Market Size, By Technology, By Value, 2019–2029

Table 5        Asia-Pacific Apheresis Market Size, By Application, By Value, 2019–2029

Table 6        Asia-Pacific Apheresis Market Size, By Country, By Value, 2019–2029

Table 7        China Apheresis Market Size, By Value (USD Million), 2019–2029

Table 8        China Apheresis Market Size, By Product, By Value, 2019–2029

Table 9        China Apheresis Market Size, By Procedure, By Value, 2019–2029

Table 10      China Apheresis Market Size, By Technology, By Value, 2019–2029

Table 11      China Apheresis Market Size, By Application, By Value, 2019–2029

Table 12      India Apheresis Market Size, By Value (USD Million), 2019–2029

Table 13      India Apheresis Market Size, By Product, By Value, 2019–2029

Table 14      India Apheresis Market Size, By Procedure, By Value, 2019–2029

Table 15      India Apheresis Market Size, By Technology, By Value, 2019–2029

Table 16      India Apheresis Market Size, By Application, By Value, 2019–2029

Table 17      Japan Apheresis Market Size, By Value (USD Million), 2019–2029

Table 18      Japan Apheresis Market Size, By Product, By Value, 2019–2029

Table 19      Japan Apheresis Market Size, By Procedure, By Value, 2019–2029

Table 20      Japan Apheresis Market Size, By Technology, By Value, 2019–2029

Table 21      Japan Apheresis Market Size, By Application, By Value, 2019–2029

Table 22      South Korea Apheresis Market Size, By Value (USD Million), 2019–2029

Table 23      South Korea Apheresis Market Size, By Product, By Value, 2019–2029

Table 24      South Korea Apheresis Market Size, By Procedure, By Value, 2019–2029

Table 25      South Korea Apheresis Market Size, By Technology, By Value, 2019–2029

Table 26      South Korea Apheresis Market Size, By Application, By Value, 2019–2029

Table 27      Australia & New Zealand Apheresis Market Size, By Value (USD Million), 2019–2029

Table 28      Australia & New Zealand Apheresis Market Size, By Product, By Value, 2019–2029

Table 29      Australia & New Zealand Apheresis Market Size, By Procedure, By Value, 2019–2029

Table 30      Australia & New Zealand Apheresis Market Size, By Technology, By Value, 2019–2029

Table 31      Australia & New Zealand Apheresis Market Size, By Application, By Value, 2019–2029

Table 32      Indonesia Apheresis Market Size, By Value (USD Million), 2019–2029  

Table 33      Indonesia Apheresis Market Size, By Product, By Value, 2019–2029    

Table 34      Indonesia Apheresis Market Size, By Procedure, By Value, 2019–2029

Table 35      Indonesia Apheresis Market Size, By Technology, By Value, 2019–2029

Table 36      Indonesia Apheresis Market Size, By Application, By Value, 2019–2029

Table 37      Malaysia Apheresis Market Size, By Value (USD Million), 2019–2029   

Table 38      Malaysia Apheresis Market Size, By Product, By Value, 2019–2029      

Table 39      Malaysia Apheresis Market Size, By Procedure, By Value, 2019–2029  

Table 40      Malaysia Apheresis Market Size, By Technology, By Value, 2019–2029

Table 41      Malaysia Apheresis Market Size, By Application, By Value, 2019–2029 

Table 42      Singapore Apheresis Market Size, By Value (USD Million), 2019–2029 

Table 43      Singapore Apheresis Market Size, By Product, By Value, 2019–2029    

Table 44      Singapore Apheresis Market Size, By Procedure, By Value, 2019–2029

Table 45      Singapore Apheresis Market Size, By Technology, By Value, 2019–2029        

Table 46      Singapore Apheresis Market Size, By Application, By Value, 2019–2029

Table 52      Vietnam Apheresis Market Size, By Value (USD Million), 2019–2029    

Table 53      Vietnam Apheresis Market Size, By Product, By Value, 2019–2029      

Table 54      Vietnam Apheresis Market Size, By Procedure, By Value, 2019–2029   

Table 55      Vietnam Apheresis Market Size, By Technology, By Value, 2019–2029 

Table 56      Vietnam Apheresis Market Size, By Application, By Value, 2019–2029 

Table 57      Rest of Asia-Pacific Apheresis Market Size, By Value (USD Million), 2019–2029         

Table 58      Rest of Asia-Pacific Apheresis Market Size, By Product, By Value, 2019–2029

Table 59      Rest of Asia-Pacific Apheresis Market Size, By Procedure, By Value, 2019–2029         

Table 60      Rest of Asia-Pacific Apheresis Market Size, By Technology, By Value, 2019–2029         

Table 61      Rest of Asia-Pacific Apheresis Market Size, By Application, By Value, 2019–2029         

Table 62      Asahi Kasei Corporation Company Overview

Table 63      Asahi Kasei Corporation Financial Overview

Table 64      B. Braun SE Company Overview

Table 65      B. Braun SE Financial Overview

Table 66      Fresenius SE & Co. KGAA Company Overview

Table 67      Fresenius SE & Co. KGAA Financial Overview

Table 68      Haemonetics Corporation Company Overview

Table 69      Haemonetics Corporation Financial Overview

Table 70      Terumo Corporation Company Overview

Table 71      Terumo Corporation Financial Overview

Table 72      Kaneka Corporation Company Overview

Table 73      Kaneka Corporation Financial Overview

Table 74      Sumitomo Bakelite Company Limited Company Overview

Table 75      Sumitomo Bakelite Company Limited Financial Overview

Table 76      Medica SPA Company Overview

Table 77      Medica SPA Financial Overview 

 

Market Segmentation

No data available
No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

Ans: Asia-Pacific Apheresis Market size was estimated at USD 1.98 billion in 2022.
Ans: Major factors driving the growth of Asia-Pacific Apheresis Market include the increasing prevalence of chronic diseases, rising demand for blood components, advancements in healthcare infrastructure, growing awareness about apheresis therapies, and growing geriatric population. Also, technological innovations and government initiatives.
Ans: Key players in Asia-Pacific Apheresis Market include Asahi Kasei Corporation, B. Braun SE, Fresenius SE & Co. KGaA, Haemonetics Corporation, Terumo Corporation, Kaneka Corporation, Sumitomo Bakelite Company Limited, and Medica SPA.
Ans: The devices segment accounts for a higher market share in the Asia-Pacific Apheresis Market by product.
Ans: The plasmapheresis segment accounts for the highest market share in the Asia-Pacific Apheresis Market by procedure.